# Multicenter Investigation of Limitation of Infarct Size (MILIS)

> **NCT00000493** · PHASE3 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)**

## Conditions studied

- Cardiovascular Diseases
- Coronary Disease
- Heart Diseases
- Myocardial Infarction
- Myocardial Ischemia

## Interventions

- **DRUG:** propranolol
- **DRUG:** hyaluronidase

## Key facts

- **NCT ID:** NCT00000493
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1977-09
- **Primary completion:** —
- **Final completion:** 1985-12
- **Target enrollment:** — (—)
- **Last updated:** 2016-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000493, "Multicenter Investigation of Limitation of Infarct Size (MILIS)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00000493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*